The use of SESN2 in the diagnosis, staging, and evaluation of response to treatment in Hashimoto’s disease will be valuable in identifying patients before clinical symptoms begin, improving their quality of life, initiating timely and effective treatment, evaluating the response, and even avoiding unnecessary treatments. The gene discussed is SESN2; the disease is Hashimoto thyroiditis.